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Abstract
Influenza A is a virus that can infect a wide range of hosts and thus has the potential to cause widespread
infection. Due to urban interactions between avian and rodent species it is possible that the common brown
rat, Rattus norvegicus could become a transmission vector, triggering an influenza epidemic or pandemic. To
test the potential for viral transmission, samples taken post mortem as swabs and tissue samples from urban
rats collected in the city of Boston were tested for the virus using RNA extraction and PCR. Preliminarily
positive results were obtained from lung tissue and oronasal swab samples and used to inoculate chicken
eggs for viral amplification. Using current methodologies, no virus was detected. Future studies may focus
on other model systems for viral amplification.
Introduction
Rattus norvegicus, common names include the
brown rat or Norway rat, were believed to have
migrated to North America on ships traveling from
Europe in 1775. Norway rats, who are known to
live in close association with human populations, are
often found in present day urban and suburban areas.
Their close interaction with humans have made them
conduits of viral disease to human populations in
the recent past. For example, the Norway rat is
believed to have been the source of an outbreak of
the Seoul Hantavirus in 2017 [Kerins, 2018]. The
outbreak was found to have started in an in-home
rattery that bred Norway rats primarily as pets. The
virus was confirmed to have spread to 31 facilities,
located throughout 11 different states in the United
States, as well as 6 ratteries in Canada. Although
no deaths occurred and only three persons were
hospitalized, this 2017 outbreak is an example of how
Norway rats are able to act as a vector spreading viral
infection among the human population in which they
cohabitate and the real possibility of a more serious
viral outbreak occurring.
2009 H1N1 Pandemic
In 2009, a new strain of influenza appeared in the
United States and Mexico. It was created from the
genetic material from influenza strains of three differ-
ent species being exchanged to create what became
the H1N1 Influenza A virus [Al-Muharrmi, 2010].
This virus was unlike most other influenza viruses
that came before it. Older individuals appeared to
have a higher immunity to the virus than younger in-
dividuals. Deaths and other complications associated
with the virus also occurred mostly in younger people.
In the span of about 2 months, the newly created
virus was announced by the WHO as a pandemic
event, the first in 40 years [WHO, 2018].
Influenza Virus
Influenza viruses are a subset of the family Or-
thomycoviridae, which cause the flu in vertebrates.
Of the viruses in this family, the genus Influenza
A most commonly infects humans. The genus
is further classified by their surface glycoproteins,
hemagglutinin [HA] and neuraminidase [NA], into
subtypes. There are 18 unique hemagglutinin types,
8 of which are able to infects humans, and 11 unique
neuraminidase types, 6 of which can infect humans
(CDC, 2017). Hemagluttanin binds to sialic acid
receptors on cells to infect them and neuraminidase
cleaves the sialic acid receptors off the host cell,
preventing agglutination of newly created virions,
allowing them to spread [Shtyrya et al., 2009].
Of the known influenza A viruses, all but two
[H17N10 & H18N11] have been found to also infect
birds. Avian influenza A viruses are designated
as highly pathogenic avian influenza (HPAI), which
include H5 and H7 subtypes, or low pathogenic-
ity avian influenza (LPAI), which can include H1-
H16 subtypes, based on molecular characteristics
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of the virus and the ability of the virus to cause
disease and mortality in chickens in a laboratory
setting [Barnard, 2009]. Influenza binds to the sialic
acid [SA] receptors in cells, which differ among
species. The difference between binding to an avian
host or human host comes from having an alpha 2,3
linked SA glycoprotein versus an alpha 2,6 linked SA
glycoprotein [E. Driskell, 2012]. Mutations affecting
a virus’s ability to bind to these receptors may
allow infection of new hosts or prevent infection of
traditional hosts.
Reassortment of genes for influenza virus has
the possibility to occur when two viruses co-infect
a cell. In cases such as these, genomic segments
can be exchanged, and novel strains of virus not
seen in nature are generated, as was the case in
the 2009 H1N1 pandemic [Al-Muharrmi, 2010]. The
influenza genome is divided into eight negative RNA
segments, which are attached to each other through
a polymerase protein complex. Reassortment events
can allow hosts previously immune to strains of a
virus to be infected. Influenza A viruses can infect a
range of different hosts other than humans. Possible
hosts include birds, pigs, horses, seals, and whales.
Different subtypes of Influenza A infect a different
range of hosts, with the exception of birds, who as
previously stated are hosts to all known Influenza A
subtypes.
Norway Rats and Influenza
It has been shown that Norway rats are able to
become infected with a type A Influenza virus (H3N2)
in an experimental setting [Daniels, 2003]. While
testing the viral influenza infection among three rat
strains (Norway, Sprague-Dawley, and Fischer-344),
Norway rats were shown to have a unique response
to the viral infection. The Sprague-Dawley and
Fischer-344 rats showed a similar infection profile and
immune response that resulted in an approximate
100-fold increase of virus titer when compared to the
Norway Rat. When confronted with this strain of in-
fluenza virus the Norway rat was able to inhibit viral
replication in the lung at a much more efficient rate
than that of the other two rat strains. This difference
was attributed to a difference in the utilization of
host defenses. Sprague-Dawley and Fischer-344 rats
were shown to have an immediate recruitment of
neutrophils and greater interleukin response, whereas
Norway Rat’s immune response tended to heavily
favor the utilization of macrophages and natural killer
cells. This unique, innate immune response could be
the reason to why Norway rats have not experienced
widespread infection with the influenza virus. If a
crossover event were to occur in the ever-changing
influenza viruses that made it to be able to better
bypass this host immune strategy, the close proximity
of Norway rats to human populations could cause an
influenza outbreak similar to that of the 2009 H1N1
pandemic.
Materials and Methods
Rat Necropsy
Rats were received from Boston Department of
Public Health, from various locations within Boston
(see Figure 1), and brought to the Cummings School
of Veterinary Medicine. Necropsies were performed
on a total of 55 rats, 32 of which were males and
23 were females. When rats were received, each was
assigned a specimen identification number (i.e. R-
300) in sequential order. Latitude and longitude of
where the rats were trapped was listed. The rats
were weighed and species, sex, and external exam
notes were recorded. Any ectoparasites were collected
and transferred into 2 mL cryovials containing 70%
ethanol. Two swab samples were then taken and
stored separately in 2 mL cryovials containing Ther-
moFisher Remel Micro Test M4RT (VTM). The first
sample included swabbing each of the rat’s paws, a
sweep of the hair, and base of tail. The second sample
was a swab of the oronasal cavity. Rats were placed
dorsally and secured. Scissors were used to open the
thoracic cavity. The lungs were removed and two
samples were retrieved. A sample of each lobe of lung
was taken and stored together in two separate 2 mL
cryovials containing VTM. The incision was extended
caudally and the abdominal cavity was then opened.
All abdominal organ samples were stored in empty 2
mL cryovials, one vial for each different sample taken.
The liver was removed and a sample of each liver lobe
was taken. The spleen was then removed and cut
into sections small enough to insert into the cryovials.
Each kidney was located and removed. Kidneys were
stored in two individual cryovials. Fecal samples were
taken from the descending colon. One sample was
placed into a cryovial containing VTM and another
placed into an empty cryovial.
In the event that only enough fecal material for
a single sample was present, the VTM sample was
prioritized. Internal examination notes were recorded
as necessary. All samples were stored at -80 degrees
Celsius until RNA extraction was to be performed.
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Figure 1: An area map of locations that rat specimens were retrieved from. The color of the marker
represents a different location in the Boston area. Red: Boston Commons/Public Garden (BC/PG), Brown:
Chinatown, Orange: N. Beacon St., Beige: South Boston, Purple: Suffolk County House of Corrections,
Green: Holocaust Museum, Black: Boston Waterfront, Blue: Garden of Remembrance Memorial, Yellow:
Roxbury
Swab Sample RNA Extraction
In order to extract viral RNA from the swab
samples and fecal samples the following extraction
protocol was performed. Samples to be extracted
were first identified and removed from the -80 degrees
Celsius freezer and transferred to the 4 degrees Cel-
sius refridgerator to thaw. For a full extraction run,
86 samples were processed across 8 ThermoFisher
KingFisher extraction plates (labeled A-H). The
biosafety cabinet, as well as all material entering
the cabinet (pipettes, tip boxes, vortex, etc.), were
treated with RNase Zap prior to extraction. This
promotes the inactivation of the RNase enzyme
that degrades RNA. Lysis mix is prepared using
the Omega Bio-tek Mag- Bind Viral DNA/RNA 96
kit (Mag-Bind R© Particles CNR, TNA Lysis Buffer,
VHB Buffer, Carrier RNA, Proteinase K Solution
(40mg/mL), SPR Wash Buffer & Nuclease Free
water). In a 15mL conical tube, 6.72 mL TNA lysis
buffer, 44.8 µL linear polyacrylamide, and 7.84 mL of
100% isopropanol are mixed. This mix was vortexed
briefly and 130 µL were transferred into every well
in Row A of each extraction plate. 200 µL of VHB
buffer are transferred into Row B of every well of
each extraction plate. In every well of both Row C
and Row D, 200 µL of SPR wash buffer are added.
In row E 50 µL of nuclease free water are added.
Each Kingfisher plate is sealed with a foil cover until
samples are ready to be added.
For extraction plates A-G 50 µL of sample are
micropipetted into an individual well of Row A. In
the last column of Row A 50 µL of VTM is added as
a negative control. In every well of Row A 10 µL of
magnetic bind-bead solution is added (contains 530
µL of Mag-Bind Beads CNR and 530 µL of proteinase
K solution). For Plate H, samples and bead solution
are added into wells A 1-9. In well 10, 50 µL of the
PR8 (Puerto Rico-8 Influenza A virus strain) positive
control is added with the magnetic bead solution.
Row 11 is left empty as a placeholder for the rtPCR
positive control. Row 12 is an identical negative
control to all the other plates containing VTM. Plates
are then transferred to the Kingfisher machine for the
extraction and wash cycles. When finished, 50 µL of
the contents of Row E (where the extracted RNA
is located) were transferred into the PCR plate. The
samples are transferred into rows in the same manner
as they were transferred to the extraction plate, wit
When all of the samples have been transferred into
the PCR plate, the plate is then covered with a plastic
plate seal cover.
Tissue Sample RNA Extractions
RNA extractions were performed on rat lung
tissue preserved in VTM at -80 degrees Celsius.
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Samples to be run were identified and removed from
the freezer to thaw. Once thawed, pieces of tissue
were added to a bead beater vial (2 mL), with
enough tissue to fill the tube approximately 1/3 of
the way full. To this vial, 600 µL of VTM was
added. The vials were then agitated using a Scientific
Industries, Inc Cell disruptor Genie at 3000 rpm for
5 minutes. Samples and tissue were then moved to
RNase/DNase-free 2mL microcentrifuge tubes. This
tube was centrifuged at a G-force of 250 for 7 minutes
and a small amount of supernatant removed. 750
µL of chilled Sigma RNAzol RT was transferred into
this tube and mixed via pipetting up and down ten
times and then 300 µL of RNase/DNase free water
was added. The tube was then repeatedly inverted
for 15 seconds. Tubes were then allowed to incubate
at room temperature for 15 minutes. Following
this incubation period, samples were centrifuged at
12,000g ( 14,000 rpm) for 15 minutes at 4 degrees
Celsius. 750- 1000 µL of the resulting supernatant
was then transferred into a separate 2 mL RNase free
tube. Isopropanol was added in an equal volume of
the extracted supernatant to the RNAse free tube.
The tube was then inverted 5-7 times and again
allowed to incubate at room temperature. After 10
minutes of incubation the tubes were then centrifuged
at 12,000g for 10 minutes at 4 degrees Celsius. If a
pellet was visible at this point, all of the supernatant
was removed from the tube. In cases where a pellet
was not visible, 50 µL of supernatant was left in
the tube. The pellets were then washed with 600
µL of 75% ethanol and inverted 5 times. Samples
were then centrifuged at 8,000g ( 11,400 rpm) for 3
minutes at 4 degrees Celsius. The supernatant was
removed, making sure not to disturb the pellet. The
ethanol wash and centrifugation process was then
repeated. The supernatant was again removed. The
pellet was resuspended in 30-100 µL of RNase free
water and vortexed for 3 minutes. If RT-PCR was
not being immediately performed, then the centrifuge
tubes were placed in a -80 degrees Celsius freezer until
needed.
Real Time PCR
All surfaces were first wiped down with Phar-
macal Quatricide (2.25% alkyl (60% C14, 30% C16,
5% C12, 5% C18), Dimethyl benzyl ammonium
chlorides, 2.25% dimethyl ethylbenzyl ammonium
chlorides, 95.5% inert ingredients). Surfaces, as well
as materials (pipettes, tip boxes, vortex, etc.), were
wiped with Molecular BioProducts DNA AWAY. The
RNA plate, created from RNA extraction samples,
was removed from the freezer and allowed to thaw
over ice. If samples were in centrifuge tubes from
a tissue sample extraction, they were used in the
place of an extraction plate. Aliquots of qSCRIPT
Quanta Toughmix (rtPCR master mix), forward and
reverse primers, and probes were also removed from
the freezer at this point. In each well of a 96-well
optical rtPCR plate the following reagents are added:
10 µL qSCRIPT Quanta Toughmix, 3.6 µL Nuclease
free water, 0.4 µL of 20 µM Avian Influenza Matrix
probe forward primer( Avian Influenza 5’ ARA TGA
GTC TTC TRA CCG AGG TCG 3’), 0.4 µL of
20 µM Avian Influenza Matrix probe reverse primer
(Avian Influenza 5’ TGA AAA GAC ATC YTC AAG
YYT CTG 3’), and 0.6 µL of 5 µM Avian Influenza
Matrix probe (Avian Influenza H5 5’ FAM-TCA ACA
GTG GCG AGT TCC CTA GCA-TAMRA 3’).
The RNA plate was spun down at 315g for
approximately 8 seconds and the bottom was wiped
down with Quatricide and DNA away. The cover of
the RNA plate was punctured and 5 µL of sample
transferred to the corresponding well on the rtPCR
plate. In column 12 of the rtPCR plate 5 µL of
water was added as a negative control. In well H11
5 µL of the PR8 RNA positive control (A/Puerto
Rico/8/1934) was added. The plate was then sealed
with a transparent optical film cover. The PCR
plate was run for one cycle at 50 degrees Celsius
for 10 minutes for cDNA synthesis and then 95
degrees Celsius for 1 minute to initiate denaturation.
Following this, 45 cycles of 95 degrees Celsius for
three seconds (allowing for denaturation) and 30
seconds at 60 degrees Celsius (allowing for annealing
and elongation) occurred. Samples were considered
positive when they produced cycle threshold values
¡45 with the primer and probe sets.
Egg Inoculation and Harvest
Chicken eggs were secured through Charles River
Laboratories and incubated at 37 degrees Celsius and
45-50% humidity. Inoculation of eggs took place after
10 days of incubation. All samples were removed from
the freezer and allowed to thaw. All surfaces of the
biosafety cabinet were wiped down with Quatricide,
as well as all materials being placed into the hood.
200 µL of each sample was then pipetted into 0.5 ml
Eppendorf tubes containing 100 µL of an antibiotic
cocktail Tubes were briefly vortexed and allowed to
incubate on ice for 1-2 hours. During this time, eggs
were removed from the incubator and placed into a
separate biosafety cabinet. Lights were turned off and
eggs were candled to check survival rates and location
of air sac and blood vessels. A small “x” was penciled
onto the outer shell of the eggs, slightly above the
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intersection of the air sac and embryo, being careful
to avoid blood vessels.
Upon completion of candling, eggs were wiped
down with 70% ethanol and placed into the biosafety
cabinet containing sample. Eggs were paired with
each of the two eggs set up to be inoculated with
the same sample. A 23G lancet was then used to
penetrate the eggs at the center of the “x” created
during the candling process. A 25G x 5/8” luer-
lock needle, attached to a 1ml syringe, was used
to draw up the 300 µL of sample (200µL sample +
100µL antibiotic cocktail). 150 µL was then injected
into the allantoic fluid of each of the two eggs that
were paired. The holes created by the lancet were
then sealed with a drop of Elmer’s glue. The glue
cap was wiped wiped down with 70% ethanol after
each egg pair. After the inoculation of all eggs,
again, they were lightly sprayed with 70% ethanol
and then transferred from the biosafety cabinet to the
incubator under the same temperature and humidity
conditions. All materials removed from the hood, as
well as all surfaces, were wiped down with Quatricide.
Eggs were then monitored for viability via candling
until it was time to harvest. Any unviable eggs
were removed from the incubator and stored in a
secondary containment unit, to be disposed of upon
the completion of the harvest of the other eggs.
After approximately 72 hours of incubation fol-
lowing inoculation, eggs were placed into a secondary
containment unit at -20 degrees Celsius for 1 hour
to euthanize embryo. Eggs were sprayed with 70%
ethanol and transferred into the biosafety cabinet.
The top of each egg was then gently cracked open
with a pair of tweezers and shell pieces removed.
A disposable spatula was then utilized to pull back
the allantoic membrane from the inside of the shell
and an 18G luer-lock needle, attached to a 10ml
syringe, was utilized to puncture the membrane.
Approximately 5 ml of allantoic fluid from each egg
of a pair was then transferred into a pre-labeled 15
ml Falcon conical tube. All tubes were stored on ice
until the completion of the harvest. Between eggs,
tweezers were wiped down with 70% ethanol and
inserted inserted into a heated glass bead sterilizer
for 10-15 seconds. All Falcon conical tubes were then
centrifuged, utilizing aerosol containment rotors, at
454g and 4 degrees Celsius for 7 minutes. The
containment rotors were then sprayed with 70%
ethanol and transferred into the biosafety cabinet
before being opened. All tubes were placed on ice
and then 1.5-2ml of each allantoic fluid sample were
aliquoted into five separate 2 ml cryovials. The
cryovials were then stored in a -80 degrees Celsius
freezer. All materials removed from the hood, as well
as all surfaces, were wiped down with Quatricide.
Results and Discussion
Cycle threshold (CT) was used to measure am-
plification of extracted RNA samples. The value
assigned to the cycle threshold was determined if or
when measured fluorescence surpasses the threshold
by assigning the cycle number to that sample. Fluo-
rescence was measured using ∆Rn or the normalized
reporter value. ∆Rn is measured by the amount of
reporter fluorescence divided by a passive reference
dye. The limit of cycle threshold values was set to 45,
meaning any sample that does not reach the threshold
by the 45th cycle will be considered negative or
undefined.
The first round of real time PCR was composed
of a mix 86 feces and various oronasal, paw, and hair
swab samples (Figure 2). No samples within this run
reached a CT value below 45.
From the second round of real time PCR,
which was performed on ten preliminary lung tis-
sue samples from ten rats (Figure 3.) There
were four samples with a CT value lower than 45
which were 17MR00206, 17MR00254, 17MR00266, &
17MR00270 (Table 1). This CT value made sample
17MR00270 an outlier from the other nine samples.
The lung sample from the specimen was used up
during the extraction process so a second lung sample
(17MR00271) from the same rat was used as a proxy
for RNA to be inoculated into eggs for viral culture
later on.
The third round of real time PCR was performed
on a full extraction plate (Figure 4), or 86 samples,
from swabs of the oronasal cavity and the paws of
Rat #201 through Rat #318. Swab samples took
much less time to extract RNA and therefore, more
samples could be tested in a shorter period of time.
Samples with the top ten lowest ct values, including
the two samples above the threshold, whose swab
samples produced low ct values. One lung sample
from each rat specimens where high swab samples
were found was put through the RNA extraction and
PCR process in an attempt to determine whether
there was a correlation between low ct values in
lung tissue and low ct values from swab samples.
Results from the PCR of these samples (Figure 5)
show sample 18MR00539, coming from Rat # 316
to approach the threshold but not pass it. Two of
the ten preliminary swab samples were found in this
specimen, meaning only eight lung tissue samples
were tested.
The fourth round of real time PCR was performed
on the extracted RNA of eight lung tissue samples:
17MR00366, 17MR00371, 17MR00406, 17MR00412,
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Table 1: In this table are the vial sample numbers and the corresponding rat the sample came from. A
measurement of ’-’ for the CT value indicates in 45 cycles of real time PCR, no significant replication of
Influenza A could be measured. Although not true positives in terms of their ct values, these stood out on
amplification plots when compared to other samples during the same round of real time PCR.
ID Location Source Pre-inoculation
CT
Post-
inoculation
CT
R201 - 17MR00206 Roxbury Lung 42.66 -
R213 - 17MR00254 BC/PG Lung 42.89 -
R216 - 17MR00266 9/11 Memorial Lung 40.61 -
R217 - 17MR00270 9/11 Memorial Lung 37.44 -
R247 - 17MR00364 BC/PG Oronasal
Swab
- -
R248 - 17MR00368 BC/PG Paw Swab - -
R250 - 17MR00409 9/11 Memorial Paw Swab - -
R255 - 17MR00404 South Boston Oronasal
Swab
- -
R305 - 18MR00429 Bradston St. Oronasal
Swab
- -
R307 - 18MR00448 BC/PG Paw Swab - -
R316 - 18MR00537 Bradston St. Paw Swab - -
R316 - 18MR00539 Bradston St. Lung - -
R325 - 18MR00620 Holocaust
Museum
Oronasal
Swab
42.63 -
R328 - 18MR00645 BC/PG Oronasal
Swab
44.05 -
R333 - 18MR00693 Holocaust
Museum
Oronasal
Swab
- -
18MR00430, 18MR00450, 18MR00539 (Figure 5).
The extracted lung tissue samples correlated to ex-
tracted oronasal and paw swab samples from the
third round of real time PCR that had the lowest
ct values. Of these eight samples, 18MR00539 stood
out from the rest based on its high amplification.
From the previous real time PCR, an extracted swab
sample from both the oronasal cavity and paws came
back with higher amplification, making this the third
sample tested from Rat #316 to come back with
evidence of influenza A exposures. Again, the sample
of lung tissue used in the extraction was used up, so a
second sample of lung tissue (18MR00540) from the
Rat #316 was used as a proxy.
On the fifth round of real time PCR, the 31
remaining swab samples to that date were tested.
(Figure 6) Three samples of the group came back
with ct values lower than 45. These samples were:
18MR00620, 18MR00645, and 18MR00693 (Table 1).
Necropsy samples were selected for inoculation
into eggs based on their ct values with consideration
of the other ct values in their respective rounds of
PCR (Table 1). A total of eight samples were selected
to be inoculated into chicken eggs: 17MR00206,
17MR00266, 17MR00270, 18MR00134, 18MR00620,
18MR00645, 18MR00693, and 18MR00539. The
process of inoculating potential virus into eggs is
done to allow virus to proliferate. After a 72 hour
period of incubation, the alantoic fluid of the eggs was
harvested, spun down using a centrifuge, and RNA
extraction and real time PCR were performed again.
No samples from the post-inoculation real time PCR
had any significant amplification of influenza virus
(Figure 7).
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Figure 2: A real time PCR amplification plot from 86 samples of extracted RNA. Oronasal swab samples,
swab samples of the paw, and fecal samples were used for extraction. Each line represents one sample. ∆Rn
values on the y-axis are equivalent to the fluorescence emission intensity of the reporter dye divided by the
fluorescence emission intensity of the passive reference dye. Ct values were taken when the ∆Rn passed the
threshold. Thresholds were placed at the highest point of the sample noise on the left of the graph. From
this round of PCR, no samples crossed the threshold and were therefore all negative.
Figure 3: A real time PCR amplification plot from 10 samples of extracted RNA. Lung tissue samples were
used for RNA extraction. Each line represents one sample. ∆Rn values on the y-axis are equivalent to the
fluorescence emission intensity of the reporter dye divided by the fluorescence emission intensity of the passive
reference dye. Ct values were taken when the ∆Rn passed the threshold. Thresholds were placed at the
highest point of the sample noise on the left of the graph. Samples 17MR00206, 17MR00254, 17MR00266,
& 17MR00270 passed the threshold below 45 cycles.
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Figure 4: A real time PCR amplification plot from 86 samples of extracted RNA. Oronasal swab samples
and swab samples of the paw were used for extraction. Each line represents one sample. ∆Rn values on the
y-axis are equivalent to the fluorescence emission intensity of the reporter dye divided by the fluorescence
emission intensity of the passive reference dye. Ct values were taken when the ∆Rn passed the threshold.
Thresholds were placed at the highest point of the sample noise on the left of the graph. From this round of
PCR, no samples crossed the threshold and were all negative.
Figure 5: A real time PCR amplification plot from 7 samples of extracted RNA. Lung tissue samples
were used for extraction. Each line represents one sample. ∆Rn values on the y-axis are equivalent to
the fluorescence emission intensity of the reporter dye divided by the fluorescence emission intensity of the
passive reference dye. Ct values were taken when the ∆Rn passed the threshold. Thresholds were placed at
the highest point of the sample noise on the left of the graph. From this round of PCR, no samples crossed
the threshold and were all negative.
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Figure 6: A real time PCR amplification plot from extracted RNA. Oronasal swab samples and swab samples
of the paw were used for extraction. Each line represents one sample. ∆Rn values on the y-axis are equivalent
to the fluorescence emission intensity of the reporter dye divided by the fluorescence emission intensity of
the passive reference dye. Ct values were taken when the ∆Rn passed the threshold. Thresholds were placed
at the highest point of the sample noise on the left of the graph.
Figure 7: A real time PCR amplification plot of eight viral RNA samples that were inoculated into chicken
eggs to amplify virus and then extracted a second time. Of the eight samples, no samples had a ct value
lower than 45. Ct values were taken when the ∆Rn passed the threshold. Thresholds were placed at the
highest point of noise created by the samples to the left. ∆Rn values are equivalent to the fluorescence
emission intensity of the reporter dye divided by the fluorescence emission intensity of the passive reference
dye. From this round of PCR, no samples crossed the threshold and were all negative.
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Though the data collected appears negative, there
may be variables causing false negative results. Low
ct values from PCR are inversely proportional to the
amount of virus found in the sample. Even if a ct
value is high, or even undetectable, virus can still
be isolated from the samples, creating false negatives
[Lindsey et al., 2013]. While this does not account
for every sample, which most likely does contain some
true negatives, keeping this in mind, it is also possible
that rats could be infected with Influenza A virus but
not shed virus in their feces or the oronasal cavity. A
low viral load to begin with may result in an inability
to detect levels of viral RNA that were in the samples.
The RNA extraction process for tissue samples
varied from the process of extracting RNA from swab
samples of both paws and the oronasal cavity. It
was assumed that viral particles would be released
from the swab and into the Viral Transport Medium
(VTM). Pairing a low viral load with failure of virus
to release into VTM could cause PCR results to show
a false negative. The RNA extraction process for
lung tissue may also decrease the viral load available
for PCR. To release the RNA from tissue, samples
were agitated using metal beads. Two concerns with
tissue agitation arose. Agitating tissue too hard may
destroy the viral capsid and RNA, making it unable
to be detected with PCR. Too little agitation, and
viral particles may not be released into the VTM
and therefore undetectable to PCR. The line between
being too rough with the sample but not forceful
enough may need to be researched more in future
experiment.
With low viral loads, extending the number of
cycles that PCR runs through may increase ct values
for samples that don’t have high levels of virus. From
choice samples seen in Figure 1 a, d & e, there are
outliers that may be able to break the threshold.
Given enough time, all samples can theoretically
break the threshold but these outlier samples may
have levels of virus that are too low to be detected
in 45 cycles of PCR but still contain virus. As
previously mentioned, Norway rats display a unique
immune response when exposed to and infected with
influenza. It is a possibility that this alternative
immune response plays a part in keeping the viral
load at suppressed enough level as to hinder the the
amplification process. This may explain why most of
the samples displayed ”weakly positive” results.
All controls for real time PCR were successful and
behaved as expected. It should be noted that these
controls were pipetted directly into the wells for PCR
and did not undergo the same extraction process as
the samples retrieved from the rats. This would ac-
count for the strong difference between the resulting
PCR values of the positive controls compared to those
of the rat samples. If the PR8 positive control had
a barrier of extraction for the RNA similar to that
of the tissue/swab samples barrier to extraction of
RNA, perhaps these values would have been more
similar.
Once all the samples that were marked as positive,
or having a ct value lower than 45, were inocu-
lated into eggs for virus amplification, no virus was
detected. Future experiments may seek to explore
different methods of culturing influenza A virus from
rats [J. Katz, 1989]. Some research teams in the past
have had difficulty amplifying non-avian influenza in
chicken eggs [C. McWhite, 2016]. One reason non-
avian influenza may not efficiently amplified in the
eggs is that non-avian influenza may be more effective
against receptors in their hosts compared to birds.
This would cause lower rates of viral amplification in
non-host species.
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